iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.99M | -5.72M | -5.16M | -- | -4.36M |
| Total Depreciation and Amortization | 241.00K | 289.00K | 293.00K | -- | 281.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.72M | 295.00K | 247.00K | -- | 461.00K |
| Change in Net Operating Assets | 792.00K | -529.00K | 8.00K | -- | -247.00K |
| Cash from Operations | -5.24M | -5.67M | -4.62M | -- | -3.87M |
| Capital Expenditure | -516.00K | -32.00K | -1.00K | -- | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.47M | -21.46M | 46.00K | -- | -1.00K |
| Cash from Investing | -2.98M | -21.49M | 45.00K | -- | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -614.00K | -160.00K | -183.00K | -- | -170.00K |
| Issuance of Common Stock | 3.65M | 324.00K | 2.41M | -- | 18.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.75M | 46.54M | 5.95M | -- | -- |
| Cash from Financing | 8.79M | 46.71M | 8.18M | -- | -152.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 561.00K | 19.55M | 3.61M | -- | -4.02M |